De-Ning Liao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
De-Ning Liao has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fei Lü
University of Minnesota, Minneapolis, MN, USA
1 shared publication Hao Wang
1 shared publicationJia-You Zhang
Department of Cardiology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
1 shared publicationLiang Zhao
Department of Cardiology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
1 shared publicationPeng Liu
1 shared publicationWei Zhao
Department of Cardiology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China
1 shared publication
Latest Publications
- 20 March 2013
- Published by China Science Publishing & Media Ltd. in Academic Journal of Second Military Medical University
- Vol. 33 (3) , 300-305
Effect of local radiofrequency denervation on ventricular effective refractory period and ventricular arrhythmia susceptibility after acute myocardial infarction
- 20 March 2013
- Published by China Science Publishing & Media Ltd. in Academic Journal of Second Military Medical University
- Vol. 33 (3) , 300-305
Effect of local radiofrequency denervation on ventricular effective refractory period and ventricular arrhythmia susceptibility after acute myocardial infarction
- 11 October 2010
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 22 (5) , 573-578
Catheter Ablation of Cardiac Fat Pads Attenuates Bezold-Jarisch Reflex in Dogs
Ablation of Cardiac Fat Pads and BJR. Background: Bezold–Jarisch reflex (BJR) plays an important role in the pathophysiology of several cardiovascular disorders. Radiofrequency catheter ablation (RFCA) of the vagal ganglia in cardiac fat pads (FPs) may attenuate BJR. The purpose of this study was to examine the effects of RFCA of the cardiac FPs on veratridine‐induced BJR in dogs. Methods and Results: This study was performed in 30 pentobarbital‐anesthetized and open‐chest dogs: control group received no ablation (n = 15); and ablation group (n = 15) received epicardial ablation of the 3 FPs located near the right pulmonary vein, the inferior vena cava, and the aortic root. The BJR was induced by injection of veratridine (15 μg/kg) into the left ventricle. Before injection of veratridine, there were no significant differences in heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), left ventricular systolic pressure (LVSP), left ventricle end‐diastolic pressure (LVEDP), left ventricular peak systolic and diastolic velocity (±dp/dtmax) between these 2 groups (P > 0.05). However, the veratridine‐induced decrease of HR in ablation group was significantly lower than that in control group (22.9 ± 8.5 bpm vs 93.3 ± 18.4 bpm, P < 0.01). There were no differences in the reduction of SAP, DAP, MAP, LVSP, LVEDP and dp/dtmax between both groups (P > 0.05). Conclusions: RFCA of the cardiac FPs significantly attenuated veratridine‐induced cardio‐vagal component but not the vasodepressor component of the BJR. This might have therapeutic implications in BJR‐related disorders such as cardio‐inhibitory vasovagal syncope. (J Cardiovasc Electrophysiol, Vol. 22, pp. 573‐578 May 2011)
- 11 October 2010
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 22 (5) , 573-578
Catheter Ablation of Cardiac Fat Pads Attenuates Bezold-Jarisch Reflex in Dogs
Ablation of Cardiac Fat Pads and BJR. Background: Bezold–Jarisch reflex (BJR) plays an important role in the pathophysiology of several cardiovascular disorders. Radiofrequency catheter ablation (RFCA) of the vagal ganglia in cardiac fat pads (FPs) may attenuate BJR. The purpose of this study was to examine the effects of RFCA of the cardiac FPs on veratridine‐induced BJR in dogs. Methods and Results: This study was performed in 30 pentobarbital‐anesthetized and open‐chest dogs: control group received no ablation (n = 15); and ablation group (n = 15) received epicardial ablation of the 3 FPs located near the right pulmonary vein, the inferior vena cava, and the aortic root. The BJR was induced by injection of veratridine (15 μg/kg) into the left ventricle. Before injection of veratridine, there were no significant differences in heart rate (HR), systolic arterial pressure (SAP), diastolic arterial pressure (DAP), mean arterial pressure (MAP), left ventricular systolic pressure (LVSP), left ventricle end‐diastolic pressure (LVEDP), left ventricular peak systolic and diastolic velocity (±dp/dtmax) between these 2 groups (P > 0.05). However, the veratridine‐induced decrease of HR in ablation group was significantly lower than that in control group (22.9 ± 8.5 bpm vs 93.3 ± 18.4 bpm, P < 0.01). There were no differences in the reduction of SAP, DAP, MAP, LVSP, LVEDP and dp/dtmax between both groups (P > 0.05). Conclusions: RFCA of the cardiac FPs significantly attenuated veratridine‐induced cardio‐vagal component but not the vasodepressor component of the BJR. This might have therapeutic implications in BJR‐related disorders such as cardio‐inhibitory vasovagal syncope. (J Cardiovasc Electrophysiol, Vol. 22, pp. 573‐578 May 2011)